1.Enhanced killing activity of γδT cells against SW1990 cells by dihydroartemisinin
Bo LU ; Fuxing CHEN ; Zhonghai ZHOU ; Leiqing SUN ; Sujuan FEI
Chinese Journal of Microbiology and Immunology 2013;(2):103-106
Objective To investigate the effect of DHA on proliferation and killing activity of γδT cells against SW1990 cells in vitro.Methods γδT cells were generated in vitro by stimulating peripheral blood mononuclear cells of healthy donors in RPMI 1640 completed medium containing IPP and IL-2 for 8 d,and then co-cultured with different concentrations of DHA for 48 h.Proliferation rates of γδT cells for each group were detected by MTT method.The perforin,granzyme B and CD107a expression in γδT cells were verified by flow cytometer.The cytotoxic activity of γδT cells against SW1990 cells were analyzed by CCK-8 kit.Results The purity of γδT cells in each group reached 75.46% ±5.32% after 8 d of culture.Compared with the control group,the proliferative capability of γδT cells were enhanced significantly after treated with 50-100 μmol/ml DHA for 48 h,moreover,cytotoxicity against SW1990 cells and perforin,granzyme B and CD107a expression of the γδT cells treated with DHA were higher than the control group.Conclusion DHA could enhance the antitumor activity of γδT cells,which may be associated with the upregulation of perforin and granzyme B expression in γδT cells.
2.To investigate the relationship of antithrombin-Ⅲ activity and thrombosis risk in liver cirrhosis with child-pugh classification
Bin GUO ; Ning XIE ; Meng YU ; Xiao CHEN ; Xueqin ZHAN ; Zhonghai FEI ; Junan LI
International Journal of Laboratory Medicine 2016;37(18):2581-2582,2586
Objective To investigate the relationship of antithrombin‐Ⅲ activity and thrombosis risk in liver cirrhosis with Child‐Pugh classification .Methods In our hospital from June to December 2014 ,60 liver cirrhosis patients were selected randomly included into this experiment group ,The 60 cases of control group were from medical examination of health in our hospital .The plasma AT‐Ⅲ activity and D‐D concentration in all these cases were detected and analyzed .Results The AT‐Ⅲ in cirrhosis patients were significantly lower than which in healthy persons(P<0 .05) .The lower level of AT‐Ⅲ is in these patients which were in seri‐ous condition(P<0 .05) ,the abnormal rate of D‐D concentration is also higher at the same time(P<0 .05) .Conclusion The detec‐tion of AT‐Ⅲ level in patients with liver cirrhosis is directly related to the severity of clinical and thrombosis risk .The AT‐Ⅲ de‐tection level can be used to judge the patient′s condition and develop appropriate treatment strategies .
3.Establishment of blood reference ranges and the comparative study of differences with national standard in northeast Sichuan area
Bin GUO ; Ning XIE ; Wen LIU ; Jinhua ZHANG ; Zhonghai FEI ; Jun'an LI ;
International Journal of Laboratory Medicine 2015;(22):3255-3256
Objective To establish blood reference ranges and compare these ranges with national standard in northeast Sichuan area .Methods Routine blood parameters of red blood cell ,white blood cell ,hemoglobin blood platelet count were detected in 12 480 healthy adult and old persons(divided groups according to gender ,age) and 1 120 neonatal from June 2013 to June 2014 in North Si-chuan Medical College Affiliated Hospital ,and concluded their routine blood reference range ,then analyzed the difference with the national standard .Results The range of red blood cells had no statistical difference compared with national standard in different age and gender groups(P>0 .05) .The ranges of white blood cell count and hemoglobin had significant differences compared with the national standard only in the neonatal group(P<0 .05) .The range of platelet count had significant difference compared with the na-tional standard in all age and gender groups(P<0 .05) in the northeast area of sichuan .Conclusion There are significant differ-ences between the partial routine blood value in the northeast area of Sichuan and the current reference range ,and might influence the clinical judgment of abnormal results .
4.Effect of hydrocortisone on proliferation and killing activity of NK cells against SW1990 cells
Chengjun XUE ; Zhonghai ZHOU ; Fuxing CHEN ; Xiaoting Lü ; Ying LI ; Sujuan FEI
Chinese Journal of Pancreatology 2013;(3):179-182
Objective To investigate the effects of hydrocortisone (HC) on proliferation and killing activity of NK cells against pancreatic cancer SW1990 cells in vitro.Methods Peripheral blood mononuclear cells of healthy people were isolated and cultured with NK cells medium containing IL-1S.When the purity of NK cells reached above 70%,different concentrations of HC (10-6,10-5,10-4,10-3 μmol/L) were added and co-cultured with NK cells for 7 days.And NK cells without HC were used as control.CD3-CD56 + NK cell numbers of each group were countered by trypan blue staining.Perforin,granzyme B and IFN-γ expression of CD3-CD56+ + NK cells were verified by flow cytometry.NK cells and SW1990 cells were co-cultured with a 20∶1effector to target ratio,then the cytotoxic activity of NK cells against SW1990 cells were analyzed by CCK-8 kit.Results After treatment with different concentration of HC for 7 days,NK cells purity of each group reached 70.72% ~ 76.39%,and it was not significantly different with that in control group [(72.61 ± 3.76) %].The proliferation folds of NK cells treated with 10-6,10-5,10-4,10-3 μmol/L HC were (9.13 ± 0.94),(9.67 ±1.51),(10.33±1.07),(8.40±1.47) times,respectively,while it was (4.23 ±0.82) times in control group (all P <0.01).The killing effects of NK cells on SW1990 cells were (58.58 ± 4.89) %,(62.27 ± 5.63) %,(64.02 ± 5.79) %,(63.88 ± 3.61) %,which were higher than that in control group [(57.46 ± 5.11) %],moreover,the difference between NK cells of 10-4 μmol/L HC treatment group and control group was statistically significant(P < 0.05).The expressions of perforins of 10-4,10-3 μmol/L HC treatment group were (96.71 ± 3.04) %,(97.56 ± 2.18) %,which were significantly higher than that in control group [(92.40 ±3.53)%,P <0.05 or 0.01].The expression of granzyme B in 10-5 μmol/L HC treatment group was (78.23 ±2.94)%,which were significantly higher than that in control group [(73.68 ±3.52) %,P <0.05].The expressions of IFN-γ in 10-5,10-4,10-3 μmol/L HC treatment group were (96.61 ±2.04)%,(97.58 ± 2.17)%,(98.00 ± 1.77)%,which were significantly higher than that in control group [(92.44 ± 2.74)%,P<0.01].Conclusions HC can promote IL-15 activated NK cells proliferation and enhance NK cells mediated killing activity against SW1990 cells with proper concentration,and up-regulation of perforin,granzyme B and IFN-γ expression may be the main mechanisms.
5.Expert consensus for the clinical application of autologous bone marrow enrichment technique for bone repair (version 2023)
Junchao XING ; Long BI ; Li CHEN ; Shiwu DONG ; Liangbin GAO ; Tianyong HOU ; Zhiyong HOU ; Wei HUANG ; Huiyong JIN ; Yan LI ; Zhonghai LI ; Peng LIU ; Ximing LIU ; Fei LUO ; Feng MA ; Jie SHEN ; Jinlin SONG ; Peifu TANG ; Xinbao WU ; Baoshan XU ; Jianzhong XU ; Yongqing XU ; Bin YAN ; Peng YANG ; Qing YE ; Guoyong YIN ; Tengbo YU ; Jiancheng ZENG ; Changqing ZHANG ; Yingze ZHANG ; Zehua ZHANG ; Feng ZHAO ; Yue ZHOU ; Yun ZHU ; Jun ZOU
Chinese Journal of Trauma 2023;39(1):10-22
Bone defects caused by different causes such as trauma, severe bone infection and other factors are common in clinic and difficult to treat. Usually, bone substitutes are required for repair. Current bone grafting materials used clinically include autologous bones, allogeneic bones, xenografts, and synthetic materials, etc. Other than autologous bones, the major hurdles of rest bone grafts have various degrees of poor biological activity and lack of active ingredients to provide osteogenic impetus. Bone marrow contains various components such as stem cells and bioactive factors, which are contributive to osteogenesis. In response, the technique of bone marrow enrichment, based on the efficient utilization of components within bone marrow, has been risen, aiming to extract osteogenic cells and factors from bone marrow of patients and incorporate them into 3D scaffolds for fabricating bone grafts with high osteoinductivity. However, the scientific guidance and application specification are lacked with regard to the clinical scope, approach, safety and effectiveness. In this context, under the organization of Chinese Orthopedic Association, the Expert consensus for the clinical application of autologous bone marrow enrichment technique for bone repair ( version 2023) is formulated based on the evidence-based medicine. The consensus covers the topics of the characteristics, range of application, safety and application notes of the technique of autologous bone marrow enrichment and proposes corresponding recommendations, hoping to provide better guidance for clinical practice of the technique.